STAT

Gawande says health venture is not seeking profits. But whose bottom line will it benefit?

Dr. Atul Gawande has described his new health care company as a “nonprofit” that will operate independently from the three massive corporations providing its funding — a firewall he said is crucial to ensuring its mission stays focused on the needs of patients.

But since he was named CEO in June, the three founders of the company — Amazon, JPMorgan Chase, and Berkshire Hathaway — have remained circumspect about the health venture’s precise legal structure, focus, and funding.

A person familiar with the inner-workings of the enterprise told STAT that its corporate creators

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks